Titlebook: Handbook of Medical and Health Sciences in Developing Countries; Education, Practice, Yaser Mohammed Al-Worafi Living reference work 2023La

欢呼

Mawkish

Peptic Ulcer Management in Developing Countries,sis and management. Peptic ulcers exert a substantial clinical burden in developing countries, often leading to hospitalizations, surgeries, and long-term medical therapy. Economically, the costs of medical care and lost productivity due to illness place a strain on individuals and healthcare system

烦躁的女人

Hypertension Management in Developing Countries,mate goal of treatment of hypertension is to decrease morbidity and mortality associated with the disease. This is achieved by controlling blood pressure to target level and controlling risk factors. In the Arab region hypertension is prevalent reflected in part by the high prevalence of overweight

Crumple

Hyperlipidemia Management in Developing Countries,cardiovascular diseases, including heart attacks and strokes. This condition is not confined to developed nations but is increasingly prevalent in developing countries, posing a pressing public health concern. This chapter explores the epidemiology, prevalence, risk factors, complications, clinical

Preserve

Angina Management in Developing Countries,significant implications for global health. This chapter provides a comprehensive overview of angina, its epidemiology, risk factors, clinical manifestations, and the challenges associated with its management in both developed and developing countries. Angina’s global burden is substantial, affectin

Neuralgia

Myocardial Infarctions in Developing Countries,ountries. According to Global Burden of Disease (GBD) data in 2019, ischemic heart disease was the leading cause of death and is expected to continue increasing in developing countries due to the expanding life expectancy, changing lifestyles and the adoption of a Western diet, and due to the increa

STAT

Antagonism

价值在贬值

Thrombosis Management in Developing Countries,ons for morbidity and mortality. While thrombosis management has made notable strides worldwide, developing countries face unique challenges in addressing this complex medical issue. This chapter discusses the prevalence, morbidity, and mortality of thrombosis in developing countries, explores the c

conference

Stroke Management in Developing Countries,th substantial economic cost of treatment and rehabilitation as well as social consequences. However, developing countries lack data, resources, policies, and structures to adequately face its burden. Generally, stroke can be ischemic or hemorrhagic with a higher prevalence of the ischemic subtype.